Table 3.
Clinical characteristics and tertiles of TR % change after exercise (pre-/postexercise difference).
| n | Lower 2 tertiles (<−0.0952 and <1.1162) |
Upper tertiles (≥1.1162) |
P value* | |
|---|---|---|---|---|
| Age, y | 30 | 57.5 ± 11.3 | 59.1 ± 6.7 | 0.685 |
| Sex, n (%) female | 11 | 6 (55) | 5 (45) | 0.425 |
| Height, m | 30 | 1.7 ± 0.1 | 1.7 ± 0.1 | 0.589 |
| Weight, kg | 30 | 84.5 ± 19.3 | 79.5 ± 17.8 | 0.501 |
| Waist, cm | 28 | 107.5 ± 46.2 | 95.9 ± 10.1 | 0.465 |
| BMI, (kg/m)2 | 30 | 28.8 ± 5.4 | 27.7 ± 3.3 | 0.567 |
| Obesity, n (%) | 10 | 8 (80) | 2 (20) | 0.419 |
| Abdominal obesity, n (%) | 13 | 8 (62) | 5 (38) | 0.505 |
| Smoker, n (%) | 21 | 12 (57) | 9 (43) | 0.204 |
| Coronary artery disease**, n (%) | 1 | 1 (100) | 0 (0) | 1.000 |
| Hypertension, n (%) | 13 | 11 (85) | 2 (15) | 0.119 |
| Diabetes, n (%) | 4 | 4 (100) | 0 (0) | 0.272 |
| Dyslipidemia, n (%) | 13 | 8 (62) | 5 (38) | 0.705 |
| Statin therapy, n (%) | 5 | 3 (60) | 2 (40) | 1.000 |
| β-Blocker therapy, n (%) | 6 | 6 (100) | 0 (0) | 0.074 |
| Aspirin therapy, n (%) | 5 | 5 (100) | 0 (0) | 0.140 |
| ACE-inhibitor therapy, n (%) | 4 | 3 (75) | 1 (25) | 1.000 |
| ASA risk score > 2, n (%) | 28 | 19 (68) | 9 (32) | 0.615 |
| Lee Cardiac Risk Index > 2, n (%) | 3 | 3 (100) | 0 (0) | 0.107 |
| Chemotherapy, n (%) | 13 | 7 (54) | 6 (46) | 0.255 |
| Radiation therapy, n (%) | 10 | 7 (70) | 3 (30) | 0.101 |
| PreOp echo/EF, % | 17 | 61.4 ± 3.8 | 62.4 ± 6.9 | 0.709 |
| PreOp hemoglobin, mg/dL | 30 | 13.3 ± 1.0 | 13.5 ± 1.4 | 0.705 |
| PreOp fasting glucose, mg/dL | 30 | 106.7 ± 28.6 | 95.8 ± 12.0 | 0.260 |
| PreOp creatinine, mg/dL | 28 | 1.0 ± 0.3 | 1.0 ± 0.2 | 0.509 |
| Length of hospital stay, d | 30 | 11.2 ± 11.7 | 12.6 ± 18.32 | 0.800 |
| Length of ICU Stay, d | 30 | 2.4 ± 9.0 | 6.3 ± 19.9 | 0.462 |
*Fisher's exact test.
**Patient status after myocardial infarction (with or without intervention).